Cyclopharm Ltd (CYC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.208x

Based on the latest financial reports, Cyclopharm Ltd (CYC) has a cash flow conversion efficiency ratio of -0.208x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.50 Million ≈ $-5.31 Million USD) by net assets (AU$36.10 Million ≈ $25.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cyclopharm Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Cyclopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Cyclopharm Ltd (CYC) financial obligations for a breakdown of total debt and financial obligations.

Cyclopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cyclopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ATrack Technology TWO:6465	-0.024x
AFC Gamma Inc NASDAQ:AFCG	-0.003x
Visaka Industries Limited NSE:VISAKAIND	0.064x
ENERGY&MACHINERY KOREA Co.Ltd KQ:095190	-0.094x
Daebo Magnetic Co.Ltd KQ:290670	-0.063x
Lesico Ltd TA:LSCO	0.226x
PUBLIC POLICY HO.COM 144A F:PD7	N/A
Kredyt Inkaso SA WAR:KRI	0.105x

Annual Cash Flow Conversion Efficiency for Cyclopharm Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of Cyclopharm Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Cyclopharm Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$42.73 Million ≈ $30.23 Million	AU$-12.57 Million ≈ $-8.90 Million	-0.294x	-31.89%
2023-12-31	AU$32.26 Million ≈ $22.83 Million	AU$-7.20 Million ≈ $-5.09 Million	-0.223x	-43.52%
2022-12-31	AU$36.54 Million ≈ $25.85 Million	AU$-5.68 Million ≈ $-4.02 Million	-0.155x	-310.91%
2021-12-31	AU$43.07 Million ≈ $30.47 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.038x	+92.75%
2020-12-31	AU$17.12 Million ≈ $12.11 Million	AU$-8.93 Million ≈ $-6.32 Million	-0.522x	-2375.37%
2019-12-31	AU$23.20 Million ≈ $16.42 Million	AU$-489.34K ≈ $-346.24K	-0.021x	+67.59%
2018-12-31	AU$17.02 Million ≈ $12.04 Million	AU$-1.11 Million ≈ $-783.51K	-0.065x	-64.56%
2017-12-31	AU$17.25 Million ≈ $12.21 Million	AU$-682.12K ≈ $-482.64K	-0.040x	-175.26%
2016-12-31	AU$12.46 Million ≈ $8.82 Million	AU$654.79K ≈ $463.31K	0.053x	-83.43%
2015-12-31	AU$13.10 Million ≈ $9.27 Million	AU$4.15 Million ≈ $2.94 Million	0.317x	-44.96%
2014-12-31	AU$7.76 Million ≈ $5.49 Million	AU$4.47 Million ≈ $3.16 Million	0.576x	+198.54%
2013-12-31	AU$3.66 Million ≈ $2.59 Million	AU$706.71K ≈ $500.04K	0.193x	+715.72%
2012-12-31	AU$15.61 Million ≈ $11.04 Million	AU$369.29K ≈ $261.29K	0.024x	-38.69%
2011-12-31	AU$14.60 Million ≈ $10.33 Million	AU$563.63K ≈ $398.80K	0.039x	+684.06%
2010-12-31	AU$13.77 Million ≈ $9.74 Million	AU$-90.96K ≈ $-64.36K	-0.007x	-102.49%
2009-12-31	AU$13.93 Million ≈ $9.86 Million	AU$3.69 Million ≈ $2.61 Million	0.265x	+132.81%
2008-12-31	AU$13.06 Million ≈ $9.24 Million	AU$1.49 Million ≈ $1.05 Million	0.114x	+472.02%
2007-12-31	AU$7.34 Million ≈ $5.20 Million	AU$146.10K ≈ $103.37K	0.020x	+100.96%
2006-12-31	AU$-566.06K ≈ $-400.52K	AU$1.17 Million ≈ $827.14K	-2.065x	-1691.99%
2005-12-31	AU$11.34 Million ≈ $8.02 Million	AU$1.47 Million ≈ $1.04 Million	0.130x	--

About Cyclopharm Ltd

AU:CYC Australia Medical Distribution

Market Cap

$61.87 Million

AU$87.44 Million AUD

Market Cap Rank

#21054 Global

#736 in Australia

Share Price

AU$0.73

Change (1 day)

-0.68%

52-Week Range

AU$0.58 - AU$1.46

All Time High

AU$3.26